Odyssey Therapeutics, Inc.
NASDAQ:ODTXBiotechnology
-$0.01 today
- Market cap
- $912.33M
- Beta
- 0.00
Volume 0.37M
Average 0.43M
ODTX Interest Income
Income earned on cash, deposits, and investments held by the company.
Interest Income history
Currency unavailable · from the income statement
No Interest Income data reported for this period type.
Interest Income vs competitors
How ODTX compares with its peers on the latest reported figures
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $34.81M USD | +48.0% | +209.8% | 38.5% | |
ORKAOruka Therapeutics, Inc. | LTM Sep 2026 | $30.52M USD | +87.1% | +191.0% | — |
| LTM Jun 2026 | $26.12M USD | -11.5% | +92.1% | 9.3% | |
ALMSAlumis Inc. Common Stock | LTM Jun 2026 | $18.44M USD | +21.1% | +92.4% | 249.2% |
| LTM Mar 2026 | $11.74M USD | -40.2% | +21.4% | 5.1% | |
| LTM Mar 2026 | $6.99M USD | -14.1% | — | 83.5% | |
| LTM Mar 2026 | $1.62M USD | -32.2% | -0.0% | — | |
AGMBAgomAb Therapeutics N.V. American Depositary Shares | FY2024 | €1.22M EUR | +397.1% | — | — |
ODTXOdyssey Therapeutics, Inc. | — | — | — | — | — |
| Peer median (excluding ODTX) | — | +4.8% | +92.2% | 38.5% | |
Competitors are the stored peer set for ODTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Odyssey Therapeutics, Inc.
NASDAQ:ODTX
Intrinsic Alpha fair value
Locked
Current Price
$18.98
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.